On September 25, 2018 Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, reported that William G. Rice, Chairman, Ph.D., President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at the following upcoming conferences (Press release, Aptose Biosciences, SEP 25, 2018, View Source [SID1234529657]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2018 Cantor Fitzgerald Global Healthcare Conference
Date: Tuesday, October 2, 2018
Time: 8:00 a.m. EDT
Format: Company Presentation
Location: Intercontinental New York Barclay Hotel, New York City
Live webcast: Cantor Fitzgerald Conference Webcast Link

·Leerink Partners Roundtable Series: Rare Disease & Oncology
Date: Wednesday, October 3, 2018
Time: 2:00 p.m. EDT
Format: Fireside Chat
Location: Lotte New York Palace Hotel, New York City
Live webcast: Leerink Partners Conference Webcast Link

·18th Annual Biotech in Europe Forum
Date: Friday, October 5, 2018
Location: Centre Congress, Basel, Switzerland

9:45 a.m. CEST – Company Presentation
12:10 p.m. CEST – Oncology II – Advanced Therapeutics Panel

The live webcasts can also be accessed through the Aptose website at www.aptose.com and will be archived shortly after the live event and available for 90 days.